Syngene schedules October results: what it means for Syngene stock

Published on 10/14/2026 at 06:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The board will review results for the half year ending September 30, 2026. For Syngene stock this means a Q1 net loss of INR 90.0 million.

Leadership and results timetable

Syngene set its next results review for October 27, 2026.
First-quarter revenue was INR 736.0 crore and net loss was INR 90.0 million.
Syngene stock was at INR 384.80 on the NSE on October 14, 2026.

Syngene, INE398R01022, Illustration mit AI erstellt.

Syngene International (ISIN INE398R01022) had scheduled a board meeting for October 27, 2026, to review second-quarter and half-year results. As Tulsian AI reported on October 8, 2026, the company will consider unaudited results for the period ending September 30, 2026, with a conference call scheduled for October 28, 2026. The timetable gives investors a defined checkpoint after a weak first quarter.

Three dates mark the transition

Syngene's current transition began on July 1, 2026, when Siddharth Mittal became managing director and chief executive officer, according to Sahi Markets. The same source said the company entered fiscal 2027 after first-quarter revenue from operations fell 16.00 percent year over year to INR 736.0 crore.

On July 29, 2026, Syngene reported a consolidated net loss of INR 90.0 million for the first quarter of fiscal 2027, after a net profit of INR 870.0 million in the first quarter of fiscal 2026, according to Sahi Markets. Operating EBITDA was INR 910.0 million, while its margin contracted to 12.00 percent from 24.00 percent.

What does the date mean?

The October 27 review is important because it will test whether the first-quarter downturn carried into the September period. The company provides integrated research, development and manufacturing services to pharmaceutical, nutrition, animal health, consumer goods and specialty chemical companies, according to Syngene International. For investors, the next report must show whether revenue stabilization is accompanied by a recovery in operating profitability.

Trading level before results

Syngene International was trading at INR 384.80 on the NSE on October 14, 2026 at 9:36 a.m. IST. Its market capitalization was INR 154.9 billion at the same timestamp, while the 52-week range was INR 344.45 to INR 678.95. The October 27 board meeting and October 28 conference call are the next dated milestones for the stock.